Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons

Neuropharmacology

Volumn 53, Issue 1, 2007, Pages 134-144

  Lopez Hernandez, Gretchen ^a   Placzek, Andon N ^a   Thinschmidt, Jeffrey S ^a   Lestage, Pierre ^b   Trocme Thibierge, Caryn ^b   Morain, Philippe ^b   Papke, Roger L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Alzheimer's disease; Brain slice; Drug delivery; Patch clamp; Schizophrenia

Indexed keywords

2 [2 (4 BROMOPHENYL) 2 OXOETHYL] 1 METHYLPYRIDINIUM; 5 HYDROXYINDOLE; ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; METHYLLYCACONITINE; PARTIAL AGONIST; PYRIDINIUM DERIVATIVE; S 24795; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; INTERNEURON; MALE; NEUROMODULATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; XENOPUS LAEVIS;

ACETYLCHOLINE; ACONITINE; ANIMALS; ANIMALS, NEWBORN; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HIPPOCAMPUS; INDOLES; INHIBITORY CONCENTRATION 50; INTERNEURONS; MALE; MEMBRANE POTENTIALS; OOCYTES; PATCH-CLAMP TECHNIQUES; PYRIDINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; XENOPUS;

EID: 34547186153     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.04.007     Document Type: Article

References (57)

1. Arendash G.W., Sengstock G.J., Sanberg P.R., and Kem W.R. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Research 674 2 (1995) 252-259
2. Bjugstad K.B., Mahnir V.M., Kem W.R., Socci D.J., and Arendash G.W. Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex. Drug Development Research 39 (1996) 19-28
3. Boulter J., Connolly J., Deneris E., Goldman D., Heinemann S., and Patrick J. Functional expression of two neural nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proceedings of the National Academy of Sciences USA 84 (1987) 7763-7767
4. Broide R.S., and Leslie F.M. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Molecular Neurobiology 20 (1999) 1-16
5. Chang Q., and Fischbach G.D. An acute effect of neuregulin 1 beta to suppress alpha 7-containing nicotinic acetylcholine receptors in hippocampal interneurons. Journal of Neuroscience 26 44 (2006) 11295-11303
6. 125I]α-bungarotoxin receptor subtypes. Molecular Pharmacology 47 (1995) 164-171
7. DelToro E.D., Juiz J.M., Peng X., Lindstrom J., and Criado M. Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. Journal of Comparative Neurology 349 (1994) 325-342
8. Endo T., Yanagawa Y., Obata K., and Isa T. Nicotinic acetylcholine receptor subtypes involved in facilitation of GABAergic inhibition in mouse superficial superior colliculus. Journal of Neurophysiology 94 6 (2005) 3893-3902
9. Farooqui A.A., and Horrocks L.A. Excitotoxicity and neurological disorders: involvement of membrane phospholipids. International Review of Neurobiology 36 (1994) 267-323
10. Frazier C.J., Rollins Y.D., Breese C.R., Leonard S., Freedman R., and Dunwiddie T.V. Acetylcholine activates an α-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. Journal of Neuroscience 18 4 (1998) 1187-1195
11. Frazier C.J., Strowbridge B.W., and Papke R.L. Nicotinic acetylcholine receptors on local circuit neurons in the dentate gyrus: a potential role in the regulation of granule cell excitability. Journal of Neurophysiology 89 6 (2003) 3018-3028
12. Gais S., and Born J. Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation. Proceedings of the National Academy of Sciences USA 101 7 (2004) 2140-2144
13. Hasselmo M.E. Neuromodulation: acetylcholine and memory consolidation. Trends in Cognitive Science 3 9 (1999) 351-359
14. Hasselmo M.E. The role of acetylcholine in learning and memory. Current Opinion in Neurobiology 16 6 (2006) 710-715
15. Hasselmo M.E., and Fehlau B.P. Differences in time course of ACh and GABA modulation of excitatory synaptic potentials in slices of rat hippocampus. Journal of Neurophysiology 86 4 (2001) 1792-1802
16. Hasselmo M.E., and McGaughy J. High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Progress in Brain Research 145 (2004) 207-231
17. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Molecular Pharmacology 48 2 (1995) 280-287
18. Ji D., and Dani J.A. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. Journal of Neurophysiology 83 5 (2000) 2682-2690
19. Ji D., Lape R., and Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31 1 (2001) 131-141
20. Jope R.S., and Gu X. Seizures increase acetylcholine and choline concentrations in rat brain regions. Neurochemistry Research 16 11 (1991) 1219-1226
21. Kametani H., and Kawamura H. Alterations in acetylcholine release in the rat hippocampus during sleep-wakefulness detected by intracerebral dialysis. Life Science 47 5 (1990) 421-426
22. Klein R.C., and Yakel J.L. Paired-pulse potentiation of alpha7-containing nAChRs in rat hippocampal CA1 stratum radiatum interneurones. Journal of Physiology (London) 568 Pt 3 (2005) 881-889
23. LeBeau F.E., Towers S.K., Traub R.D., Whittington M.A., and Buhl E.H. Fast network oscillations induced by potassium transients in the rat hippocampus in vitro. Journal of Physiology (London) 542 Pt 1 (2002) 167-179
24. Levin E.D., Bradley A., Addy N., and Sigurani N. Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 109 (2002) 757-765
25. Li F., Endo T., and Isa T. Presynaptic muscarinic acetylcholine receptors suppress GABAergic synaptic transmission in the intermediate grey layer of mouse superior colliculus. European Journal of Neuroscience 20 8 (2004) 2079-2088
26. Li Y., Papke R.L., He Y.-J., Millard B., and Meyer E.M. Characterization of the neuroprotective and toxic effects of α7 nicotinic receptor activation in PC12 cells. Brain Research 81 4 (1999) 218-225
27. Marks M.J., Stitzel J.A., Romm E., Wehner J.M., and Collins A.C. Nicotine binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and α-bungarotoxin. Molecular Pharmacology 30 (1986) 427-436
28. Marrosu F., Portas C., Mascia M.S., Casu M.A., Fa M., Giagheddu M., Imperato A., and Gessa G.L. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Research 671 2 (1995) 329-332
29. McQuiston A.R., and Madison D.V. Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. Journal of Neuroscience 19 8 (1999) 2887-2896
30. Meyer E., Kuryatov A., Gerzanich V., Lindstrom J., and Papke R.L. Analysis of 40H-GTS-21 selectivity and activity at human and rat α7 nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics 287 3 (1998) 918-925
31. Meyer E.M., King M.A., and Meyers C. Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. Brain Research 786 (1998) 252-254
32. Meyer E.M., Tay E.T., Papke R.L., Meyers C., Huang G., and de Fiebre C.M. Effects of 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) on rat nicotinic receptors and memory-related behaviors. Brain Research 768 (1997) 49-56
33. Meyer E.M., Tay E.T., Zoltewicz J.A., Papke R.L., Meyers C., King M., and Fiebre C.M.D. Neuroprotective and memory-related actions of novel α7 nicotinic agents with different mixed agonist/antagonist properties. Journal of Pharmacology and Experimental Therapeutics 284 (1998) 1026-1032
34. Mori M., Gahwiler B.H., and Gerber U. Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. Journal of Physiology (London) 539 Pt 1 (2002) 191-200
35. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Molecular Pharmacology 39 (1990) 9-12
36. Papke R.L., Meyer E., Nutter T., and Uteshev V.V. Alpha7-selective agonists and modes of alpha7 receptor activation. European Journal of Pharmacology 393 1-3 (2000) 179-195
37. Papke R.L., and Papke J.K.P. Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis. British Journal of Pharmacology 137 1 (2002) 49-61
38. Papke R.L., Papke J.K.P., and Rose G.M. Activity of alpha7-selective agonists at nicotinic and serotonin receptors expressed in Xenopus oocytes. Bioorganic & Medicinal Chemistry Letters 14 8 (2004) 1849-1853
39. Pichat P., Bergis O.E., Terranova J.P., Urani A., Duarte C., Santucci V., Gueudet C., Voltz C., Steinberg R., Stemmelin J., Oury-Donat F., Avenet P., Griebel G., and Scatton B. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 17 1 (2006) 17-34
40. Pidoplichko V.I., and Dani J.A. Applying small quantities of multiple compounds to defined locations of in vitro brain slices. Journal of Neuroscience Methods 142 1 (2005) 55-66
41. Radcliffe K.A., Fisher J.L., Gray R., and Dani J.A. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Annals of the New York Academy of Science 868 (1999) 591-610
42. Ren K., Thinshmidt J., Liu J., Ai L., Papke R.L., King M.A., Hughes J.A., and Meyer E.M. alpha7 nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation. Neuroscience 101 1 (2007) 160-167
43. Scremin O.U., and Jenden D.J. Time-dependent changes in cerebral choline and acetylcholine induced by transient global ischemia in rats. Stroke 22 5 (1991) 643-647
44. Seguela P., Wadiche J., Dinely-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. Journal of Neuroscience 13 2 (1993) 596-604
45. Selina Mok M.H., and Kew J.N. Excitation of rat hippocampal interneurons via modulation of endogenous agonist activity at the alpha7 nicotinic ACh receptor. Journal of Physiology (London) 574 Pt 3 (2006) 699-710
46. Sullivan J.P., Decker M.W., Brioni J.D., Donnelly-Roberts D., Anderson D.J., Bannon A.W., Kang C.-H., Adams P., Piattoni-Kaplan M., Buckley M.J., Gopaladrichnan M., Williams M., and Arneric S.P. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. Journal of Pharmacology and Experimental Therapeutics 271 (1994) 624-631
47. Tatsumi R., Fujio M., Takanashi S., Numata A., Katayama J., Satoh H., Shiigi Y., Maeda J., Kuriyama M., Horikawa T., Murozono T., Hashimoto K., and Tanaka H. (R)-3′-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5′ -oxazolidin]-2′-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties. Journal of Medicinal Chemistry 49 14 (2006) 4374-4383
48. Thinschmidt J.S., Frazier C.J., King M.A., Meyer E.M., and Papke R.L. Medial septal/diagonal band cells express multiple functional nicotinic receptor subtypes that are correlated with firing frequency. Neuroscience Letters 389 3 (2005) 163-168
49. Thinschmidt J.S., Frazier C.J., King M.A., Meyer E.M., and Papke R.L. Septal innervation regulates the function of alpha7 nicotinic receptors in CA1 hippocampal interneurons. Experimental Neurology 195 2 (2005) 342-352
50. Uteshev V.V., Meyer E.M., and Papke R.L. Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors. Brain Research 948 1-2 (2002) 33-46
51. Uteshev V.V., Meyer E.M., and Papke R.L. Regulation of neuronal function by choline and 4OH-GTS-21 through a7 nicotinic receptors. Journal of Neurophysiology 89 4 (2003) 33-46
52. Van Kampen M., Selbach K., Schneider R., Schiegel E., Boess F., and Schreiber R. AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors. Psychopharmacology (Berlin) 172 4 (2004) 375-383
53. Whiting P.J., and Lindstrom J.M. Purification and characterization of a nicotinic acetylcholine receptor from chick brain. Biochemistry 25 (1986) 2082-2093
54. Wishka D.G., Walker D.P., Yates K.M., Reitz S.C., Jia S., Myers J.K., Olson K.L., Jacobsen E.J., Wolfe M.L., Groppi V.E., Hanchar A.J., Thornburgh B.A., Cortes-Burgos L.A., Wong E.H., Staton B.A., Raub T.J., Higdon N.R., Wall T.M., Hurst R.S., Walters R.R., Hoffmann W.E., Hajos M., Franklin S., Carey G., Gold L.H., Cook K.K., Sands S.B., Zhao S.X., Soglia J.R., Kalgutkar A.S., Arneric S.P., and Rogers B.N. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure-activity relationship. Journal of Medicinal Chemistry 49 14 (2006) 4425-4436
55. Woodruff-Pak D.S., Green J.T., Coleman-Valencia C., and Pak J.T. A nicotinic cholinergic agonist (GTS-21) and eyeblink classical conditioning: acquisition, retention, and relearning in older rabbits. Experimental Aging Research 26 4 (2000) 323-336
56. Woodruff-Pak D.S., Li Y., and Kem W.R. A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Research 645 (1994) 309-317
57. Zwart R., De Filippi G., Broad L.M., McPhie G.I., Pearson K.H., Baldwinson T., and Sher E. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacology 43 3 (2002) 374-384